• Feasibility of Use of Medical Transcription Data for Real World Evidence Generation in the United States- A Pilot Study of Patients with Systemic Lupus Erythematosus Initiated on Belimumab

    Nov 1, 2013, 00:00

  • Public Preference Elicitation in Drug Reimbursement Using Multi-Criteria Decision Analysis (MCDA) for Universal Health Insurance System in South Korea

    Nov 1, 2013, 00:00

  • Essential Medicine List (Cuadro Básico) in México. Is It a Guideline for Decision Making on the Current and Future Health Needs?

    Nov 1, 2013, 00:00

  • Long-Term Prolonged-Release Fampridine Treatment and Health-Related Quality of Life Outcomes- Interim Results of the Enable Study

    Nov 1, 2013, 00:00

  • Health Outcomes at 6 to 120 Months Since Heart Transplant in Spain- Clinical Status, Health Related-Quality of Life and Utility Assessment

    Nov 1, 2013, 00:00

  • Market Access of Implantable Medical Devices- Evidentiary Requirements Across Global Markets

    Nov 1, 2013, 00:00

  • Trastuzumabe Para Câncer De Mama Com Superexpressão De HER-2- Evidência De Eficácia, Segurança E Estimativa De Custo

    Nov 1, 2013, 00:00

  • Functional Outcomes with Aripiprazole Once-Monthly in Two Double-Blind, Placebo- and Active-Controlled Studies (Aspire US 246 and Aspire EU 247) for the Treatment of Schizophrenia

    Nov 1, 2013, 00:00

  • Disponibilidad Y Fuentes De La Información Para La Toma De Decisiones En Reumatología- Uso De Los Estudios Económicos

    Nov 1, 2013, 00:00

  • Assessment of the Budgetary Impact of Improving the Use of Evidence-Based Medicine in the Treatment of Patients with Heart Failure and Left Ventricular Dysfunction in England

    Nov 1, 2013, 00:00

  • Modeling the Cardiovascular Effects of Switching Patients from Rosuvastatin to Atorvastatin

    Nov 1, 2013, 00:00

  • Parameter Uncertainty in Value Based Multi Criteria Decision Analysis- A Systematic Review of Methods

    Nov 1, 2013, 00:00

  • The Expected Health Economic Value of Using Circulating Tumor Cells to Personalize Cancer Treatment

    Nov 1, 2013, 00:00

  • The Potential Cost-Effectiveness of Obinutuzumab (Ga101) in Combination with Chlorambucil in Chronic Lymphocytic Leukemia

    Nov 1, 2013, 00:00

  • Health-Related Quality of Life and Utility in Patients with Diabetic Foot Syndrome - An EQ-5D Survey in Poland

    Nov 1, 2013, 00:00

  • A Quebec Economic Evaluation for 36 Months of Ranibizumab for the Treatment of Diabetic Macular Edema

    Nov 1, 2013, 00:00

  • Wellbeing, Life Satisfaction and Progression in Alzheimer’s Disease – An Alsova Follow-Up Study

    Nov 1, 2013, 00:00

  • A Review of Methods Used in Health Economic Models of Chronic Myeloid Leukemia Interventions

    Nov 1, 2013, 00:00

  • A Methodology for Predicting the Impact of Copayments on the Utilization of Health Technologies

    Nov 1, 2013, 00:00

  • The Burden of Resistant Hypertension in 5 European Countries

    Nov 1, 2013, 00:00

  • The Impact of Memory Problems on Diabetes Treatment in the United Kingdom

    Nov 1, 2013, 00:00

  • Oral Hypoglycaemic Medicine (OHM) Initiation in Newly Treated Type 2 Diabetes Mellitus (T2DM) in Ireland- An Analysis of Treatment Intensification and Switching Patterns

    Nov 1, 2013, 00:00

  • Eliciting Patients’ Preferences for Epilepsy Diagnostics- A Discrete Choice Experiment

    Nov 1, 2013, 00:00

  • Medication Use Patterns and Adherence After Initiating Antipsychotics Treatment for Patients with Schizophrenia in Tianjin, China

    Nov 1, 2013, 00:00

  • Análisis Costo-Efectividad Del Tratamiento Farmacológico Para Las Manifestaciones Clínicas Mucocutáneas De La Enfermedad De Behcet

    Nov 1, 2013, 00:00

  • Clinical, Epidemiological and Economic Metrics Difference Between HPV-Related and Traditional Head and Neck Cancers

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Biologic Drugs for Treatment of Poliarticular Juvenile Rheumatoid Arthritis in Russia

    Nov 1, 2013, 00:00

  • Identification of the Treatment Pathway of Metastatic Castrate-Resistant Prostate Cancer in Scotland- A Chart Review

    Nov 1, 2013, 00:00

  • Variability in Hybrid Drug Availability and Pricing in Europe

    Nov 1, 2013, 00:00

  • Cost-Minimization Analysis of Intravitreal Aflibercept (IVT-AFL) for Neovascular Age-Related Macular Degeneration in Spain

    Nov 1, 2013, 00:00

  • Waiting Times and Scheduling in Dermatological Practices in Germany

    Nov 1, 2013, 00:00

  • Glycemic, Lipid, and Blood Pressure Control Among Type 2 Diabetes Mellitus Patients in Dubai

    Nov 1, 2013, 00:00

  • Differential Discouting- Capturing the Value of Living Longer and Better

    Nov 1, 2013, 00:00

  • Economic and Quality-Of-Life Burden of Moderate to Severe Irritable Bowel Syndrome with Constipation (IBS-C) in Spain- Interim Analysis of the IBIS-C Study

    Nov 1, 2013, 00:00

  • Assessment of Methodological Quality of Economic Evaluations in Belgian Drug Reimbursement Applications

    Nov 1, 2013, 00:00

  • Generic Substitution in Ireland – The Views of Key Stakeholders

    Nov 1, 2013, 00:00

  • Using Lower Cost, Lower Efficacy Interventions Can Improve Population Health Outcomes Under Budget Constraints

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Biosimilar Infliximab Treatment for Rheumatoid Arthritis in Six Central European Countries

    Nov 1, 2013, 00:00

  • Australian Standard Costs and Consequences of Four Chemotherapy Adverse Events

    Nov 1, 2013, 00:00

  • Proxy Utility Assessment in Acute Heart Failure

    Nov 1, 2013, 00:00

  • Efficacy and Safety of Treatments of Type 2 Diabetes Mellitus (T2DM)- A Systematic Review (Slr)

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Sequential First- and Second-Line Treatments in Metastatic Renal Cell Carcinoma Using Real-World Data and a Patient-Level Simulation Model

    Nov 1, 2013, 00:00

  • Health-Economic Comparison of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for the Treatment of Adult Type 1 Diabetes in Kazakhstan

    Nov 1, 2013, 00:00

  • Which Should Be the Correct NMA to Be Used? A Review of HTA Recommendations

    Nov 1, 2013, 00:00

  • The Development and Validation of a Quality of Life Measure for People with Mild Cognitive Impairment (The MCQ)

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Empiric Liposomal Amphotericin B Versus Voriconazole in Turkey

    Nov 1, 2013, 00:00

  • Uncovering the Gap Between Model Validation Recommendations and Practice

    Nov 1, 2013, 00:00

  • Cost Effectiveness Analysis of Boceprevir (BOC) Added to Pegifn/Ribavirin (P/R) Versus Pegifn/Ribavirin (Current Standard of Care) for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Greece

    Nov 1, 2013, 00:00

  • Efficacy of Inhaled Antibiotics in CF Patients with Chronic P. Aeruginosa Infection- A Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Time Dependent Resource Use and Costs Associated with Different States of Disease in Patients Diagnosed with HER-2 Positive Metastatic Breast Cancer

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Dabigatran Etexilate for the Secondary Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in the United Kingdom

    Nov 1, 2013, 00:00

  • HR-QOL Data in the Amnog Early Benefit Assessment- Industry and IQWIG/GBA Perspective

    Nov 1, 2013, 00:00

  • Decison Making Under Uncertainty- Coverage with Evidence Development in the Context of Medical Devices

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of the Optical Imaging Agent Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder Cancer

    Nov 1, 2013, 00:00

  • Factors Associated with Poor Adherence in Patients Initiating Medication for Major Depressive Disorder- Interim Results from a Prospective, Longitudinal Study

    Nov 1, 2013, 00:00

  • The Burden of Untreated Patients Experiencing Symptoms of Overactive Bladder

    Nov 1, 2013, 00:00

  • Adherence to Warfarin Treatment in Brazil- Systematic Review of the Literature

    Nov 1, 2013, 00:00

  • Perception of Country-Specific Health Care Reform and Consideration of Real World Evidence in Routine Practi Survey of Oncologists in European Union, United States, China and Brazil

    Nov 1, 2013, 00:00

  • Towards Evidence-Based European Policy in Clinical Trials the Survey of Attitudes Towards Trial Sites in Europe - The SAT-EU StudyTm

    Nov 1, 2013, 00:00

  • A Lesson Learnt from Avastin®- - Bevacizumab Induced Hypertension as a Predictive Biomarker of Patient Response in Overcoming Regulatory and Health Technology Assessment (HTA) Hurdles

    Nov 1, 2013, 00:00

  • Threshold Selection in Biomarkers Using Cox Regression. An Application to Non-Small-Cell Lung Cancer

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of a 13-Valent Conjugate Pneumococcal Vaccination Program in COPD Patients Aged ≥50 Years in Spain- Preliminary Results

    Nov 1, 2013, 00:00

  • Comparing the Performance of the EQ-5D-5L with the EQ-5D-3L in Stroke Patients in Japan

    Nov 1, 2013, 00:00

  • Análisis Costo-Efectividad De Everolimus Más Exemestano Para Pacientes Con Cáncer De Mama Avanzado Con Receptores Hormonales Positivos (RE+), HER2–, Que Fallaron a Los Inhibidores De Aromatasa No Esteroideos (IANES) En México

    Nov 1, 2013, 00:00

  • Burden of L-Dopa-Induced Dyskinesia in Parkinson’s Disease Patients (PD-LID) in France – the Lidia Study Economic Analysis (Levodopa Induced Dyskinesia Impact Evaluation)

    Nov 1, 2013, 00:00

  • Validation of Surrogate Endpoints in Advanced Solid Tumours- Systematic Review of Statistical Methods, Results, and Implications for Policy Makers

    Nov 1, 2013, 00:00

  • Comparison of Development Diagnosis Related Groups Base Rate in Hungary and Germany

    Nov 1, 2013, 00:00

  • Interim Results from the Burden of Bowel Dysfunction in Spinal Cord Injury Study

    Nov 1, 2013, 00:00

  • Review of the Use of Resource Use Instruments Based on Patient Recall in Relation to Other Methods of Cost Estimation

    Nov 1, 2013, 00:00

  • Economic Evaluation of an Urine Closed Collection System Versus a Traditional Open Device in Non-Pregnant Women

    Nov 1, 2013, 00:00

  • What Clinical Benefits Could Be Expected from the Implementation of a Rotavirus Vaccination Programme in France?

    Nov 1, 2013, 00:00

  • Validation of the French Translated Version of the Osteoporosis Specific Morisky Medication Adherence Scale (OS-MMAS) in France

    Nov 1, 2013, 00:00

  • Amnog Benefit Assessment- Time Delay of Market Access for Pharmaceuticals in Germany?

    Nov 1, 2013, 00:00

  • Costs of HER 2 Negative, Hormonal Receptor Positive, Metastatic Breast Cancer (MBC-HR+) Treated with Everolimus (EVE) + Exemestane (EXE) in the Brazilian Private System (BPS)- A Real World (RW) and Published Literature Analysis

    Nov 1, 2013, 00:00

  • Cost-Per-Responder Analysis of Biological Agents for the Treatment of Active Ankylosing Spondylitis in Germany

    Nov 1, 2013, 00:00

  • Access to Medicines Index- Measuring How Well Countries Provide Access to Medicines

    Nov 1, 2013, 00:00

  • Probabilistic Sensitivity Analysis to Analyze the Cost-Effectiveness of Oral Hypoglycemic Agents in the Initial Oral Drug Treatment of Outpatients Diagnosed with Type 2 Diabetes in Primary Care

    Nov 1, 2013, 00:00

  • In-Hospital and Long-Term Mortality and Morbidity Burdens in Patients with Acute Coronary Syndromes

    Nov 1, 2013, 00:00

  • Editorial Board

    Nov 1, 2013, 00:00

  • The First Experiences with Reassessments and Appraisals of Conditionally Approved Expensive and Orphan Drugs in the Netherlands (2006-2013)

    Nov 1, 2013, 00:00

  • Pricing of “Follow-On” Drugs and Competition Within Pharmaceutical Classes- Evidence from Germany 1993-2008

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad De Los Profesionales De Enfermeria Con Experiencia Laboral En Uci Versus Sin Experiencia Laboral En El Error De La Medicación Parenteral En Pacientes Adultos Hospitalizados En Uci

    Nov 1, 2013, 00:00

  • Evolução Do Uso De Medicamentos Genéricos No Tratamento De Doenças Crônicas – Pbm Brasileira

    Nov 1, 2013, 00:00

  • Estimación De La Prevalencia De Artritis Reumatoide En México

    Nov 1, 2013, 00:00

  • Comparisons of the Risk for Venous Thromboembolism Between Hip and Knee Arthroplasty Using Korea National Health Insurance Claims Database

    Nov 1, 2013, 00:00

  • User Preferences for Stroke Services in Wales

    Nov 1, 2013, 00:00

  • How Hypoglycemia Impacts Quality of Life and Treatment Satisfaction in Type 2 Diabetes Mellitus Patients on Basal-Bolus Insulin Therapy?

    Nov 1, 2013, 00:00

  • Comparative Cost-Consequence Analysis of the Bivalent and Quadrivalent Vaccines Against HPV in Spain

    Nov 1, 2013, 00:00

  • Understanding Patterns of Monitoring of Appropriate Prescribing in Europe

    Nov 1, 2013, 00:00

  • Impact of Major Clinical Events on Utilities in the Context of Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) Treated with Dialysis

    Nov 1, 2013, 00:00

  • Which Are the Attitudes of Primary Health Services Users Concerning Cost Sharing Measures in a Period of Economic Crisis in Greece?

    Nov 1, 2013, 00:00

  • Estimated Osteoporotic Population and the Related Medication Consumption in Municipality Level – Discrepancies Observed Through Data Visualization Approach

    Nov 1, 2013, 00:00

  • Use of Real-World Evidence (RWE) to Validate a Trial-based Health Economic Model

    Nov 1, 2013, 00:00

  • Argentinian Survey in Cost of Illness and Unmet Needs in Multiple Sclerosis- Treatment Experience the Costs of MS Patients in Argentina

    Nov 1, 2013, 00:00

  • Orphan Drug Legislations- Heyday or Had Their Day?

    Nov 1, 2013, 00:00

  • Comparative Economic Analysis of Retreatment Strategies for HCV Genotype 1 Patients in Russia

    Nov 1, 2013, 00:00

  • Budget Impact of Dienogest in Treating Endometriosis Associated Pelvic Pain in Brazil- A Public Perspective Analysis

    Nov 1, 2013, 00:00

  • Validation of Disease States in Schizophrenia- Comparison of Cluster Analysis Between the United States and European Populations

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Las Cintas De Uretra Media Comparadas Con El Tratamiento Convencional De La Incontinencia Urinaria Femenina De Esfuerzo En Colombia

    Nov 1, 2013, 00:00

  • Difference in Interdialytic Intervals Leading to Hospital Admission and Mortality in Hemodialysis Patients

    Nov 1, 2013, 00:00

  • Análisis Bibliométrico De La Producción Científica En Economía De La Salud En Latinoamérica

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Tocilizumab in Combination with Methotrexate Versus Standard of Care for the Treatment of Rheumatoid Arthritis in Greece

    Nov 1, 2013, 00:00

  • Estimation of the Cost of Complications Related to Glycated Hemoglobin in the Italian Diabetes Type 1 Population

    Nov 1, 2013, 00:00

  • Health Transformation Program Impact on Import and Local Pharmaceutical Consumption in Turkey

    Nov 1, 2013, 00:00

  • Prevalence of Comorbidities Among Chronic COPD Patients in the United States

    Nov 1, 2013, 00:00

  • Use of the Clinical Practice Research Datalink (CPRD) to Assess ‘Real-World’ Management of Tuberous Sclerosis Complex (TSC) in the United Kingdom

    Nov 1, 2013, 00:00

  • The Minimal Important Decrease of Health Utility in Living Kidney Donors

    Nov 1, 2013, 00:00

  • The Impact of Commodities and Extra-Articular Manifestations in Rheumatoid Arthritis Patients

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Clopidogrel Versus Ticagrelor, Ambos En Combinación Con Asa, Para El Manejo Del Síndrome Coronario Agudo, Desde La Perspectiva Del Sistema De Salud Privado En México

    Nov 1, 2013, 00:00

  • EQ-5D Utility Weights Associated with Response to Treatment with Matrix Applied Autologous Cultured Chondrocytes (MACI) Implant and Microfracture for Cartilage Defects of the Knee

    Nov 1, 2013, 00:00

  • Predicting EQ-5D Utility Scores from SF-36 Scores in Patients with Rheumatoid Arthritis in Japan

    Nov 1, 2013, 00:00

  • The Burden of Clostridium Difficile in Spain- A Retrospective Matched-Cohort Study

    Nov 1, 2013, 00:00

  • Impact of Cardiovascular Disease on Labour Force Participation- Bivariate Probit Analysis

    Nov 1, 2013, 00:00

  • Modelling the Health Technology Assessment (HTA) Process for Innovative Drug Technologies (IDTS) in the Turkish Health Care System

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Intravitreal Aflibercept in Treating Neovascular Age-Related Macular Degeneration in Sweden

    Nov 1, 2013, 00:00

  • Boceprevir Use in Fran A Markov Model of Disease Progression and Cost-Effectiveness for Chronic Hepatitis C (Virus G1)

    Nov 1, 2013, 00:00

  • Variabilidade No Tratamento Do Cancer De Mama No Brasil

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Asenapine Versus Atypical Antipsychotics Used in Turkey in the Treatment of Schizophrenia

    Nov 1, 2013, 00:00

  • Costo-Efectividad Del Screening Y Tratamiento De Hipoacusia Bilateral En Recién Nacidos (Rn) En Chile

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Carbapenems in Treatment Nosocomian Pneumonia in Ukraine

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Tocilizumab in Rheumatoid Arthritis, in Colombia

    Nov 1, 2013, 00:00

  • Using Rasch Analysis to Co-Calibrate Scores from Outcome Measures Specific to Asthma (ALIS), Chronic Obstructive Pulmonary Disease (LCOPD) and Pulmonary Hypertension (CAMPHOR)

    Nov 1, 2013, 00:00

  • Adherence Rates for Intravenous Chemotherapy Regimens to Treat Colon Cancer

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine in a Basal-Bolus Regimen in Patients with Type 1 Diabetes Mellitus in the United Kingdom

    Nov 1, 2013, 00:00

  • Translation and Cultural Adaptation of Patient Perception of Arrhythmia Questionnaire in Poland

    Nov 1, 2013, 00:00

  • Quantifying the Direct and Indirect Costs Associated with Severe and Non-Severe Hypoglycaemia in Subjects with Type-2 Diabetes Who Are Treated with Insulin

    Nov 1, 2013, 00:00

  • Using Structural Equation Modeling to Detect Response Shift and True Change in Health-Related Quality-Of-Life Scores of Breast Cancer Patients After Surgery

    Nov 1, 2013, 00:00

  • Health Care Cost of Controlled Versus Uncontrolled Type 2 Diabetes Patients in Greece

    Nov 1, 2013, 00:00

  • Economic Evaluation of HPV Vaccination Program in South Korea

    Nov 1, 2013, 00:00

  • The Relationship Between Asthma-Specific Quality of Life and Measures of Asthma Control and Generic Quality of Life

    Nov 1, 2013, 00:00

  • Potentially Inappropriate Prescribing (PIP) and Its Association with Instrumental Activities of Daily Living (IADL) Impairment in Older People

    Nov 1, 2013, 00:00

  • Coronary Artery Disease, Diabetes, and Health-Related Quality of Life- Findings of a Cohort Study from India

    Nov 1, 2013, 00:00

  • Treatment Patterns for Parkinson’s Disease- Real-World Evidence from the EU5 (France, Germany, Italy, Spain, and the United Kingdom)

    Nov 1, 2013, 00:00

  • Persistence with Medications- A Discrete Choice Experiment of Preferences Among Hypertensive Patients

    Nov 1, 2013, 00:00

  • Economical Losses Due to Disablementparents Carring for Children with Oncohematological Diseases

    Nov 1, 2013, 00:00

  • Modelling the Natural History of Schizophrenia- Comparison of Naïve Versus Advanced Statistical Methods

    Nov 1, 2013, 00:00

  • Peritonitis Fluid Treatment in Russian Federation- Evaluation of Economical Burden in Real Clinical Practice

    Nov 1, 2013, 00:00

  • Defining Eligible Patient Population in São Paulo State Based on Cleopatra Trial Inclusion Criteria- A Retrospective Analysis of Fundação Oncocentro (FOSP) Cancer Patient Registry (Registro Hospitalar Do Câncer – RHC)

    Nov 1, 2013, 00:00

  • Update of the Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID)- Inclusion of E-PRO Information

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Mirabegron Compared with Tolterodine ER 4mg for the Treatment of Patients with Overactive Bladder in the United Kingdom- Results from a Trial-Based Model

    Nov 1, 2013, 00:00

  • Point of Care Tests- The Long and Winding Road to Reimbursement

    Nov 1, 2013, 00:00

  • Feasibility of Medicines Review to Reduce Potentially Inappropriate Medicines in the Elderly- The OPTI-SCRIPT Cluster Randomized Controlled Trial

    Nov 1, 2013, 00:00

  • A Comparison of the Relative Weights of Health Domains on Global Retrospective and Experienced Health and Well-Being

    Nov 1, 2013, 00:00

  • Pilot Testing of the Polish Pre-Final Version of “Disabilities of the Arm, Shoulder and Hand” (Dash) Questionnaire

    Nov 1, 2013, 00:00

  • Economic Burden of Coronary Heart Disease in the Patients Attending National Heart Center, Kathmandu, Nepal

    Nov 1, 2013, 00:00

  • Would a New Therapy for Children Be Refused in the Context of the German Amnog?

    Nov 1, 2013, 00:00

  • Cost-effectiveness Analysis in the Treatment of Heavy Menstrual Bleeding in Spain

    Nov 1, 2013, 00:00

  • The Potential Impact of Amnog-Triggered International Referenc Pricing- A Scenario from DPP-IV Inhibitors

    Nov 1, 2013, 00:00

  • Organizational and Economic Issues Related to the Introduction of Boceprevir in the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Italy

    Nov 1, 2013, 00:00

  • Audit of the Coverage Decision-Making Process in a Government Agency in Uruguay- From the Guidelines Till the Patients

    Nov 1, 2013, 00:00

  • A Budget Impact and Cost-Effectiveness Analysis of Blood Glucose Monitoring System in One Italian Region

    Nov 1, 2013, 00:00

  • Cell Therapies- Assessing the Patient Access Opportunities and Challenges That Lie Ahead

    Nov 1, 2013, 00:00

  • Caregiver Burden in Fragile X Syndrome as a Function of a Health State Utility Index in the United States

    Nov 1, 2013, 00:00

  • Comparative Effectiveness of Conservative Therapy Versus Cystectomy for Non-Muscle Invasive Bladder Cancer Patients

    Nov 1, 2013, 00:00

  • Barriers to Biologic Therapy Use for Autoimmune Disorders in Emerging Markets

    Nov 1, 2013, 00:00

  • Effects of Changing Health Policy on Pharmacoeconomics and Health Outcome Studies from 2000 to 2012 in Turkey

    Nov 1, 2013, 00:00

  • Children with Atopic Dermatitis- Monitoring a French Cohort Over a Nine-Year Period

    Nov 1, 2013, 00:00

  • A Cost–Effectiveness And Budget Impact Analysis of Different Biologic Treatments for Psoriasis in Colombia

    Nov 1, 2013, 00:00

  • Divergence of HTA Decisions Across Countries- Case Analysis of Ivabradine

    Nov 1, 2013, 00:00

  • Analyzing Costs Per Clinical Remission of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Rheumatoid Arthritis from a Public Perspective in Brazil

    Nov 1, 2013, 00:00

  • Market Access of Cancer Drugs in European Countries- A Matter of Setting Priorities for Resource Allocation

    Nov 1, 2013, 00:00

  • An Analysis of Priscription and Reimbursement of Potentially Inappropriate Medication (PIM) in a German Practice Network

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Apixaban for the Prevention of Venous Thrombo-Embolism in Patients Undergoing Orthopedic Replacement Surgery in Italy

    Nov 1, 2013, 00:00

  • Bivariate Indirect Comparison Meta-Analysis Model in Economic Evaluation of Cancer Treatments

    Nov 1, 2013, 00:00

  • The Impact of the Economic Recession and Pharmaceutical-Health Service Agreement on the Probability and Time of Reimbursement of New Medicines in Ireland

    Nov 1, 2013, 00:00

  • Epidemiology and Economic Studies on Patients Diagnosed with Insomnia- A Review of the Literature

    Nov 1, 2013, 00:00

  • Clinical Outcomes and Health Care Costs Evaluation of Sulfonamides and Thiazolidinediones Compared with Dipeptidyl Peptidase 4 Inhibitors for the Treatment of Uncontrolled Diabetes

    Nov 1, 2013, 00:00

  • Integrating the Long-Term Health Burden of Oral Corticosteroids in the Cost-Effectiveness of Omalizumab

    Nov 1, 2013, 00:00

  • Economic Evaluation of the Impact of New Treatment Alternatives on Market Dynamics in Respiratory Diseases; A Case Study in Turkish Health Care System

    Nov 1, 2013, 00:00

  • Effects of Excess Use of Coronary Angiography and Its Association with Mortality Rates, Health Care Costs and Hospital Quality in Turkey

    Nov 1, 2013, 00:00

  • The Patient-Reported Outcomes Measurement Information System in Spanish

    Nov 1, 2013, 00:00

  • Economic Evaluation of Intravenous Iodinated Contrast Media in Italy

    Nov 1, 2013, 00:00

  • Determinants of Non-Adherence to Medications Among Chronic Patients in Maccabi Health Care Services

    Nov 1, 2013, 00:00

  • Are Generic Drugs Defined and Classified Consistently Around the World?

    Nov 1, 2013, 00:00

  • Associations Between Overall Care Experience Ratings and Utility and Psychological Well-Being in Men Recently Diagnosed with Prostate Cancer- Findings from a Population-Based Study

    Nov 1, 2013, 00:00

  • The Use of Oral Anticoagulation Drugs for Stroke Prevention in Nonvalvular Atrial Fibrilation in France, Italy, Germany, Spain and the United Kingdom- Is Current Practice Consistent with the 2012 ESC Recommendations?

    Nov 1, 2013, 00:00

  • Evaluating the Burden of Bone Metastases (BM) on Patients with Castration-Resistant Prostate Cancer (CRPC) and Their Treating Physicians- Findings from a Routine Practice Study in 13 Medium-Sized European Countries

    Nov 1, 2013, 00:00

  • Affordability of Antihypertensive Treatment in Mexico

    Nov 1, 2013, 00:00

  • Estimating the Health Outcome of Treating Type 2 Diabetic Population to Target in Local Municipality Level

    Nov 1, 2013, 00:00

  • Adrenal Insufficiency- Burden of Disease in France in 2011

    Nov 1, 2013, 00:00

  • Prevalence and Risk Factors of Depression in Patients with Chronic Obstructive Pulmonary Disease in India

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Apixaban Versus Standard of Care for the Prevention of Stroke- An Analysis of Patients with Atrial Fibrillation in Greece

    Nov 1, 2013, 00:00

  • Analysis of Transparency Amongst International Health Technology Assessment Organizations

    Nov 1, 2013, 00:00

  • Faulty Connections- Can Criticisms of Network Meta-Analysis in Nice Submissions Be Avoided?

    Nov 1, 2013, 00:00

  • Health-Economic Assessment of the Use of Catheter-Based Renal Denervation in Patients with Resistant Hypertension in Mexico

    Nov 1, 2013, 00:00

  • Treatment Satisfaction in Patients with Atrial Fibrillation on New Oral Anticoagulants as Measured with Pact-Q2- Prefer in AF Registry

    Nov 1, 2013, 00:00

  • Obesity Trends 2006-2012 in the United States- Results from the National Health and Wellness Survey

    Nov 1, 2013, 00:00

  • Patient-Reported Outcome Measures for Systemic Lupus Erythematosus Clinical Trials- A Content Validity and Psychometric Performance Review

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of the Systematic Identification and Treatment of Comorbid Major Depression for People with Chronic Diseases- The Example of Cancer

    Nov 1, 2013, 00:00

  • Resultados De La Encuesta “Change Pain” Latinoamericana- Diagnostico Y Tratamiento Actual De Los Pacientes Con Dolor Crónico

    Nov 1, 2013, 00:00

  • A Nationwide Survey on Patient Safety Culture in Japan

    Nov 1, 2013, 00:00

  • From “Generic Scheme” to “Brand-Generic Scheme”- The Effect of New Policy (2003-2004) on Efficiency of Iranian Pharmaceutical Industry

    Nov 1, 2013, 00:00

  • Real World Management and Costs in Unresectable Metastatic Melanoma (MM) Patients- Update of a Pilot Study Based on an Institutional Patient Registry

    Nov 1, 2013, 00:00

  • Early Response to Certolizumab Pegol in Rheumatoid Arthritis Predicts Outcome at One Year

    Nov 1, 2013, 00:00

  • Health Technology Assessment Report for Positron Emission Tomography in Patients with Cancer

    Nov 1, 2013, 00:00

  • Treatment Patterns and Costs Associated with Chronic Lymphocytic Leukemia Chemotherapy Under the Brazilian Private Health Care Perspective- A Retrospective Analysis of the Orizon Database

    Nov 1, 2013, 00:00

  • Expanding the Measurement of Treatment Benefit in Rheumatoid Arthritis- The Role of the Patient-Reported Outcome Consortium’s RA Working Group

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Capsule Endoscopy (Pillcam®) in the Diagnosis of Small Bowel Crohn’s Disease

    Nov 1, 2013, 00:00

  • One Line Does Not Make a Picture- Real-World Cost-Effectiveness of Multiple Myeloma Treatments Using a Full Disease Model

    Nov 1, 2013, 00:00

  • The Affordability of Oncology and HIV/AIDS Technologies in Brazil Compared to the United States and Other OECD Countries

    Nov 1, 2013, 00:00

  • Costo-Utilidad De Intervenciones Preventivas Contra El Cáncer De Cuello Uterino En Mujeres Peruanas

    Nov 1, 2013, 00:00

  • Clinical Practice Guideline Major Depressive Disorder for General Practitioners

    Nov 1, 2013, 00:00

  • Enteral Diets (ED)- A Cost-Comparison Analysis for In-Hospital Preparations Based on Real World Observation

    Nov 1, 2013, 00:00

  • Utilizing Storytelling to Promote Rational Antibiotic Use in 9-11 Years Old School Children in Iran

    Nov 1, 2013, 00:00

  • Comparative Efficacy of Blood Pressure Lowering Drugs in Primary Prevention for Elderly Patients

    Nov 1, 2013, 00:00

  • Follow-On Health Care Costs in Patients with Acute Coronary Syndrome (ACS)

    Nov 1, 2013, 00:00

  • Estimating the Budget Implications of Radium Ra 223 Dichloride in Castration-Resistant Prostate Cancer Patients with Non-Visceral Bone Metastases Treated in Infusion Centers in the United States

    Nov 1, 2013, 00:00

  • Pharmacotherapeutic Monitoring of Patients Using Immunobiological in a Health Insurance Company in Brazil- To Know to Better Manage

    Nov 1, 2013, 00:00

  • Patient-Centered Outcomes in Upper Limb Spasticity- Results from a Large International Cohort Study (ULIS-2)

    Nov 1, 2013, 00:00

  • Risk of Psychiatric and Neurological Diseases in Patients with Workspace Mobbing Experience in Germany- A Retrospective Database Analysis

    Nov 1, 2013, 00:00

  • How the Pricing Strategy of 2nd Generation HCV Direct Antiviral Agents Can Affect the Number of Treated Patients in Italy and the National Drug Budget

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Ioversol Versus Iohexol for Diagnostic Procedures

    Nov 1, 2013, 00:00

  • Effect of Nurse-Led Medication Reviews in Psychiatric Patients – An Interventional Study

    Nov 1, 2013, 00:00

  • Cost and Cost-Effectiveness Analyses for Moderate and Severe COPD Patients Treated Uniquely with Tiotropium 18 Mcg Od for Twenty-Four Months

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in Colombia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Hepatitis C Virus (HCV) Treatment with Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy Versus Waiting for New Regimens in France

    Nov 1, 2013, 00:00

  • Reaching the Middle of the Pyramid- Implications for the PMA of Pharmaceutical Drugs with the Expanding Middle Class in Brasil, Chile and Colombia

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Pharmacogenetic Screening Prior to Initiation of Carbamazepine Treatment for Epilepsy

    Nov 1, 2013, 00:00

  • The Relative Efficacy and Safety of Simeprevir and Telaprevir in Treatment-Naïve Hepatitis C Infected Patients in a Japanese Population – A Bayesian Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Empirical Evidence for the Validity and Reliability of Resource-Use Measures Based on Patient Recall- A Systematic Review

    Nov 1, 2013, 00:00

  • Variation in Treatment Patterns and Outcomes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Across European Countries

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Prepex Device and Dorsal–Slit Technique for Scaling-Up Adult Safe Medical Male Circumcision in HIV Prevention in Rural Central Uganda

    Nov 1, 2013, 00:00

  • Sources of Long-Term Quality Adjusted Life Year (QALY) Gains for Canagliflozin (CANA) Versus Sitagliptin (SITA) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting

    Nov 1, 2013, 00:00

  • Revisión De Estudios Del Coste De La Enfermedad

    Nov 1, 2013, 00:00

  • Are ICER Threshold Values Malleable? The Case of Life-Extending Cancer Treatments at the End of Life

    Nov 1, 2013, 00:00

  • An Economic Evaluation Alongside a Clinical Trial (EEACT) in Pelvic Floor Medicine

    Nov 1, 2013, 00:00

  • Added Value and Future Adoption of a New Medical Imaging Technology for Interventional Cardiology

    Nov 1, 2013, 00:00

  • The Future of Individual Funding Requests in Clinical Commissioning Groups Era

    Nov 1, 2013, 00:00

  • The Effect of Positive Margins on Outcomes in Breast Cancer

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Different Antiviral Therapies in the Treatment of Russian Patients with Chronic Hepatitis C

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Apixaban Versus Dabigatran for Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation in Spain

    Nov 1, 2013, 00:00

  • EVPI Curves in Practice

    Nov 1, 2013, 00:00

  • Remote Patient Monitoring in CRT-D Recipients May Reduce Use of Hospital-Based Care

    Nov 1, 2013, 00:00

  • Preliminary Results Quality of Life, Physical Activity, and Sedentary Behavior in College Students

    Nov 1, 2013, 00:00

  • Mixed Treatment Comparison of Adverse Events for BG-12, Glatiramer, and Teriflunomide for the Treatment of Relapsing Forms of Multiple Sclerosis

    Nov 1, 2013, 00:00

  • Loss of Productivity in Polish Patients with Rheumatoid Arthritis

    Nov 1, 2013, 00:00

  • Technical Errors in Cost-Effectiveness Models- Evidence from the Single Technology Appraisal Programme in England and Wales

    Nov 1, 2013, 00:00

  • Advanced Budget Notification (ABN)- Is There a Win-Win for Manufacturers and Payers Given the Current Austerity Measures Across the EU

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Adherence to Antiretroviral Treatment (ART) by HIV Patients- An Analysis with the Quebec (Canada) Public Drug Plan Database

    Nov 1, 2013, 00:00

  • Stage-Based Utilization of Chemotherapy Agents in a Canadian Breast Cancer Population

    Nov 1, 2013, 00:00

  • Diagnosis of Pancreatic Exocrine Insufficiency in Chronic Pancreatitis, Pancreatic Cancer and Gastrointestinal or Pancreatic Surgery Patients- A Systematic Literature Review and Expert Consensus on the Accuracy of Diagnostic Test Used in Sp ...

    Nov 1, 2013, 00:00

  • Costs Evaluations of Ready-To-Use Propofol Syringes Versus Syringes Drawn from Vials in Critically Ill

    Nov 1, 2013, 00:00

  • Budget Impact and Thresholds- How Are Real Decisions Made? - Expected Utility or Prospect Theory?

    Nov 1, 2013, 00:00

  • Treatment Patterns and Burden of Illness of Acromegaly in the United Kingdom- Real World (RW) Data from Clinical Practice Research Datalink (CPRD)

    Nov 1, 2013, 00:00

  • Budget Impact Analisis of Switching from DPT and Monovalent Vaccines to DTaP–IPV-Hib Combined Vaccine into Russian Immunization Schedule

    Nov 1, 2013, 00:00

  • The Relationship Between Submitted Line of Therapy and Reimbursement Decisions in Solid State Tumor Cancer Drugs

    Nov 1, 2013, 00:00

  • The Financial Impact of Increasing Home-Based High Dose Haemodialysis and Peritoneal Dialysis

    Nov 1, 2013, 00:00

  • Argentina’s Generic Drug Law- Was It Successful?

    Nov 1, 2013, 00:00

  • Ações De Farmacovigilância- Relato De Notificações De Medicamentos À Agência Nacional De Vigilância Sanitária (ANVISA) – Brasil

    Nov 1, 2013, 00:00

  • Real Life Applications of Social Security Institution (SSI) Regulations; A Case Study of DPP4 Inhibitors in Treatment of Diabetes in Turkish Health Care System

    Nov 1, 2013, 00:00

  • Utilisation and Costs of Inpatient and Outpatient Services Among Patients with Irritable Bowel Syndrome- A Study Using the Clinical Practice Research Datalink (CPRD)

    Nov 1, 2013, 00:00

  • Price Differences Triggered by the Availability of Biosimilars in Developed Countries

    Nov 1, 2013, 00:00

  • Understanding the Effect of Clostridium Difficile Infection on Hospital Mortality in England, the Netherlands, and Spain

    Nov 1, 2013, 00:00

  • The Budget Impact Analysis of Deferasirox for the Treatment of Iron Overload Due to Frequent Blood Transfusions in Children and Adolescents (Age ≤18 Years)

    Nov 1, 2013, 00:00

  • Estimating the Impact of Endogenous Substance Abuse on Self-Reported Health Status

    Nov 1, 2013, 00:00

  • The Estimated Survival of Patients with Double Refractory Chronic Lymphocytic Leukaemia; A Reanalysis of NICE TA202 Using Bayesian Methodology to Model Observed Data

    Nov 1, 2013, 00:00

  • Drivers of Clinician Prescribing Decisions and the Economics of Information

    Nov 1, 2013, 00:00

  • The Burden of Illness of Pulmonary Arterial Hypertension- A Managed Care Perspective in the United States

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Insulin Degludec Compared with Insulin Glargine for Patients with Type 2 Diabetes Mellitus Initiating Insulin Therapy in the United Kingdom

    Nov 1, 2013, 00:00

  • WITHDRAWN

    Nov 1, 2013, 00:00

  • Design of a Randomized Controlled Trial (RCT) Evaluating Outcome and Cost-Effectiveness of a Local Case Management Intervention of Patients Suffering from Chronic Obstructive Pulmonary Disease (COPD)

    Nov 1, 2013, 00:00

  • Pulse Pressure and Stroke Risk- Development and Validation of a Stroke Risk Equation

    Nov 1, 2013, 00:00

  • Responder Analysis of Functional Health and Well-Being in MDD- A Pooled Analysis of SF-36 Results from Three Phase III Trials with Levomilnacipran SR

    Nov 1, 2013, 00:00

  • Benefit of Adding Panitumumab to FOLFOX4 in Patients with KRAS/NRAS Wild-Type (WT) Metastatic Colorectal Cancer (mCRC)- A Number-Needed-To-Treat (NNT) Analysis

    Nov 1, 2013, 00:00

  • Schizophrenia and Negative Symptoms – Burden of the Disease in Seven Central and Eastern European (CEE) Countries- THE Results of the Literature Review

    Nov 1, 2013, 00:00

  • Long-Term Costs and Survival Associated with Immunosuppressant Following Liver Transplantation- A Markov Model

    Nov 1, 2013, 00:00

  • Estimates of Price and Income Elasticity in Gree Greek Debt Crisis Transforming Cigarettes into a Luxury Good

    Nov 1, 2013, 00:00

  • Two-Way Sensitivity Analysis- Showing the Impact of Correlated Parameters in Cost-Effectiveness Analyses

    Nov 1, 2013, 00:00

  • Investigating the Economic Impacts of New Public Pharmaceutical Policies in Greece

    Nov 1, 2013, 00:00

  • Evaluación Económica Del Uso De Dos Tratamientos Farmacológicos En Degeneración Macular Relacionada Con La Edad De Tipo Exudativa (Dmre) Para Venezuela

    Nov 1, 2013, 00:00

  • Association Between Cognitive Function and 3 Month Health Care Costs Among Patients Initiating an Antidepressant for Depressive Disorder in an Ambulatory Care Setting

    Nov 1, 2013, 00:00

  • Validity of QOL Impact Attributions to Specific Diseases- A Multitrait-Multimethod Comparison

    Nov 1, 2013, 00:00

  • Tobramycin Powder for Inhalation for the Treatment of Cystic Fibrosis- Analysis of the RAMQ Data

    Nov 1, 2013, 00:00

  • The Rand Negative Impact of Asthma on Quality of Life Item Bank and Short-Forms

    Nov 1, 2013, 00:00

  • Cost-effectiveness of Maternal Toxoplasma Screening in Austria- A Decision-analytic Model

    Nov 1, 2013, 00:00

  • Length of Stay and Outcomes for Adolescents Treated for Substance Use Disorder- An Analysis of Dose Respose Using Propensity Scores

    Nov 1, 2013, 00:00

  • Direct Cost of Diabetes Mellitus and Its Complications in Spain. Seccaid Study- Spain Estimated Cost Ciberdem-Cabimer in Diabetes

    Nov 1, 2013, 00:00

  • Risk Factors for Discontinuation of Insulin Pump Therapy in Pediatric and Young Adult Patient Groups

    Nov 1, 2013, 00:00

  • Patient Survey Data Results- Preferences for Reminders in Pro Studies

    Nov 1, 2013, 00:00

  • A Parent-Administered But Child-Completed Patient-Reported Outcome (PRO) Provides a Measure with Content Validity That Is Valid and Reliable for Use in Children Aged 6 to 11 Years

    Nov 1, 2013, 00:00

  • Examining the Effects of a Functional Restoration and Pain Management Program Among Chronic Pain Patients in the Texas Workers Compensation System- Pilot Study – Part I

    Nov 1, 2013, 00:00

  • Evaluating the Efficacy of Biosimilar Infliximab with the ACR50 Response in Patients with Rheumatoid Arthritis; A Meta-Analysis in Bayesian Framework

    Nov 1, 2013, 00:00

  • Crohn’s Disease- An Economic Assessment of Biological Drugs in Italy

    Nov 1, 2013, 00:00

  • Parental Preferences for Rotavirus Vaccination and Potential Vaccination Coveragein Young Children- A Discrete Choice Experiment

    Nov 1, 2013, 00:00

  • Patients with Chronic Hepatitis C Virus Treated with Simeprevir Added to Peginterferon and Ribavirin Experienced Less Time with Fatigue, Depressive Symptoms, and Functional Limitations- Results from Patients in the Quest-1, Quest-2, and Pro ...

    Nov 1, 2013, 00:00

  • A Relationship Between Body Mass Index and Health-Related Quality of Life Among Koreans with Diabetes- The Korea National Health and Nutrition Examination Survey

    Nov 1, 2013, 00:00

  • Dynamic Modeling to Estimate the Economic Impact of Increasing Influenza Vaccination in the United States

    Nov 1, 2013, 00:00

  • Análisis De Costo-Efectividad Del Uso De Estatinas En La Prevención De Eventos Cardiovasculares En Colombia

    Nov 1, 2013, 00:00

  • Patients’ and Caregivers’ Preferences for Bone Metastases (BM) Treatments in the United States

    Nov 1, 2013, 00:00

  • A Comparative Study on the Cost of Antibiotics for the Years 2011-2012 in Three General Hospitals of Greece

    Nov 1, 2013, 00:00

  • Serious Adverse Events for Biologic Response Modifiers Indicated for the Prophylaxis Against Transplant Rejection. an Insight from Spontaneous Adverse Event Reporting System

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus a DPP-4 Inhibitor in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales

    Nov 1, 2013, 00:00

  • Disease Becomes Social. Health Research Conducted On, or Using, Web 2.0 Media- A Systematic Review

    Nov 1, 2013, 00:00

  • Points to Consider in Multiregional Trials Using PHQ-9- A Meta-Analysis on PHQ-9

    Nov 1, 2013, 00:00

  • Barriers of Access to Elective Orthopedic Procedures in Rio De Janeiro, Brazil

    Nov 1, 2013, 00:00

  • Value Judgments in Health Technology Assessment Process in Brazil

    Nov 1, 2013, 00:00

  • Costs in Patients Along First Year Poststroke in Spain

    Nov 1, 2013, 00:00

  • Modelling the Cost-Effectiveness of First Line Biologics for Rheumatoid Arthritis in Ireland

    Nov 1, 2013, 00:00

  • Assessment of Cost-Effectiveness Models for Biologics in the Management of Severe Ankylosing Spondylitis

    Nov 1, 2013, 00:00

  • Adherence to Antiretroviral Therapy Among HIV-Infected Patients Attending to a University Infectious Diseases Clinic in Venezuela

    Nov 1, 2013, 00:00

  • Respiratory Syncytial Virus Hospitalizations in the Canadian Registry for Synagis (CARESS)

    Nov 1, 2013, 00:00

  • The Burden of Illness of Chronic Thromboembolic Pulmonary Hypertension- A Managed Care Perspective in the United States

    Nov 1, 2013, 00:00

  • Should There Be an Option to “Unrefer” Nice Single Technology Appraisals- Case Study of Aripiprazole for Bipolar I Disorder in Adolescents

    Nov 1, 2013, 00:00

  • Comparing the Health Care Costs and Utilizations Between Patients with Anxiety Versus Those Without

    Nov 1, 2013, 00:00

  • Skeletal-Related Events Have a Significant Impact on Health-Related Quality of Life in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC) Following Docetaxel Therapy Failure

    Nov 1, 2013, 00:00

  • Handling Variability in Time Endpoints in Multi-Centre Time and Motion (TM) Studies- A Case Study of Erythropoiesis-Stimulating Agents for Anaemia Management in 13 Centres in Italy

    Nov 1, 2013, 00:00

  • Age and Gender Distribution of Outpatient Care Physiotherapy Services for Dorsopathia Diseases in Hungary

    Nov 1, 2013, 00:00

  • Economic Evaluation of an Electrical Impedance Spectroscopy (EIS) Device Used as an Adjunct to Colposcopy

    Nov 1, 2013, 00:00

  • A Disease Model of Metastatic Colorectal Cancer Including Multiple Treatment Lines

    Nov 1, 2013, 00:00

  • Cost Effectiveness Analysis for the Use of Extended Release Quetiapine as Adjunctive Therapy in Mexican Adult Patients with Major Depressive Disorder Non-Responders to Antidepressant Treatment

    Nov 1, 2013, 00:00

  • The Association Between Severity of ‘Average’ Pain (NPRS) and the EQ-5D Index in Patients with Neuropathic Pain

    Nov 1, 2013, 00:00

  • Análisis Costo-Utilidad De Dos Alternativas Para El Tratamiento De Bebés Prematuros En Bogotá

    Nov 1, 2013, 00:00

  • Validación De Un Cuestionario Para Medir Riesgo De Cáncer De Piel

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Cysteamine in the Treatment of Patients with Cystinosis – a Rare Disease

    Nov 1, 2013, 00:00

  • A Cost-Utility Analysis of Lighterlife Total as a Treatment for Obesity in the United Kingdom

    Nov 1, 2013, 00:00

  • Mapping the Oxford Hip Score (OHS) to EQ-5D- A Test of Model Performance

    Nov 1, 2013, 00:00

  • Atopic Dermatitis- Evaluation of 2 Different Drug Related Managements

    Nov 1, 2013, 00:00

  • Costs of Pilot Programs Employing Allied Health Professionals Within the Centers for Population Health and Health Disparities

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Study of Nutrition Support (NS) Usage During Intensive Treatment

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of a New Fixed-Dose Combination Inhaler for a Clinical Commissioning Group within the National Health Service in England

    Nov 1, 2013, 00:00

  • Guiding Principles for Effective Private Health Insurance in Emerging Markets

    Nov 1, 2013, 00:00

  • Treatment Satisfaction and Its Association with Health Outcomes in Patients with Neuropathic Pain

    Nov 1, 2013, 00:00

  • An Overview of Domestic Cancer Drugs in Turkey- 2008-2012

    Nov 1, 2013, 00:00

  • Experiencia Inicial Con Un Nuevo Tipo De Documento De Evaluación De Tecnología Sanitaria- “Informes De Mesa De Ayuda”

    Nov 1, 2013, 00:00

  • Validation of the Multiple Sclerosis International Quality of Life Questionnaire in Electronic Form Using Item Response Theory

    Nov 1, 2013, 00:00

  • Economic Evaluation of Ceftobiprole Compared to a Combination of Linezolid with Ceftazidime in the Management of Hospitalised Pneunomia in Scotland

    Nov 1, 2013, 00:00

  • The Cost-Effectiveness of Dapagliflozin (Forxiga®) Versus Glipizide in the Treatment of Type 2 Diabetes Mellitus (T2DM) in England and Wales

    Nov 1, 2013, 00:00

  • Challenges of Conducting Economic Evaluations Using Linked Electronic Health Records - CPRD and HES in the United Kingdom

    Nov 1, 2013, 00:00

  • Review of Nice Technology Appraisals in Oncology- How Does Clinical Evidence Change Over Time?

    Nov 1, 2013, 00:00

  • Linguistic Translation and Cultural Adaptation of Functional Assessment of Chronic Illness Therapy-Tuberculosis Instrument into Arabic Language

    Nov 1, 2013, 00:00

  • A Comparison of Demographic and Clinical Variables of Down Syndrome Patients in Utah and the United States

    Nov 1, 2013, 00:00

  • Ánalise De Significância Do Banco De Dados De Hospitais Particulares Brasileiro

    Nov 1, 2013, 00:00

  • Evaluating Willingness-To-Pay Threshold for Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade- A Contingent Valuation Survey

    Nov 1, 2013, 00:00

  • Multiple Imputation Techniques for Survey Data with Multiple Rating Scales

    Nov 1, 2013, 00:00

  • Adrenal Insufficiency- Burden of Disease and Cost of Illness

    Nov 1, 2013, 00:00

  • Evaluating Economic Burden of Tick-Borne Encephalitis. Evidence from Russia

    Nov 1, 2013, 00:00

  • Conditional Survival (CS) Probabilities for Advanced Melanoma Patients Treated with Ipilimumab- Model Based Analysis

    Nov 1, 2013, 00:00

  • Health Economic (HE) Data Requirements and Availability in the European Union. Results of a Survey

    Nov 1, 2013, 00:00

  • The Diabetic Peripheral Neuropathic Pain Impact (DPNPI) Measure – Psychometric Validation of a New Patient Reported Outcome Measure

    Nov 1, 2013, 00:00

  • Integración De Un Marco Conceptual Para La Evaluación De La Calidad De Servicios Farmacéuticos Hospitalarios Enfocados a La Mejora De La Farmacoterapia

    Nov 1, 2013, 00:00

  • Treatment Patterns of Ranibizumab and Aflibercept for the Management of Wet Age-Related Macular Degeneration in Routine Clinical Practice in the United States

    Nov 1, 2013, 00:00

  • Pet-Based Radiotherapy Treatment Planning Is Highly Cost-Effective Compared to CT-Based Planning- A Model-Based Evaluation

    Nov 1, 2013, 00:00

  • Patient Preferences and Priorities for Anti-Epileptic Drug Treatment

    Nov 1, 2013, 00:00

  • ISPOR 4th Latin America Conference Disclosure Information

    Nov 1, 2013, 00:00

  • Costs of Primary Biliary Cirrhosis Treatment with Ursodeoxycholic Acid in Brazil

    Nov 1, 2013, 00:00

  • Budget Impact of an Individualized Approach in the Treatment of HBeAg-Negative CHB Patients Exploiting the Week-12 Peginterferon Alfa-2a Stopping Rule in Italy

    Nov 1, 2013, 00:00

  • Impacto De La Diabetes Sobre La Productividad En Argentina

    Nov 1, 2013, 00:00

  • Are Monoclonal Antibodies Still Considered as Innovative by the French Health Care System? A Retrospective Analysis 2000-2012

    Nov 1, 2013, 00:00

  • The Impact of Amnog on Drug Reimbursement in Germany

    Nov 1, 2013, 00:00

  • Adjusting for Treatment Switching in Clinical Trials When Only Summary Data Are Available – An Evaluation of Potential Methods

    Nov 1, 2013, 00:00

  • Perception of Users of Drug Distribution Program in Brazil

    Nov 1, 2013, 00:00

  • Minimal Important Difference (MID) of Response to the Hepatitis-C Virus Patient Reported Outcomes (HCV-PRO) Instrument in a Trial of Pegylated Interferon/Ribavirin (pegIFN/RBV) and Direct-Acting-Antivirals (DAA)

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela

    Nov 1, 2013, 00:00

  • Perfil De Adesão Aos Planos De Benefício Em Medicamentos

    Nov 1, 2013, 00:00

  • Hemangioma Family Burden- Creation of a Specific Questionnaire

    Nov 1, 2013, 00:00

  • Health Economic Evidence for Medical Nutritions- Are These Interventions Value for Money?

    Nov 1, 2013, 00:00

  • Budget Impact of Metastatic Castrate-Resistant Prostate Cancer (CRPC) to German Payers

    Nov 1, 2013, 00:00

  • Diffusion of the Efficiency Frontier Approach Within Health Economic Evaluation- Current and Future Applications

    Nov 1, 2013, 00:00

  • Costo-Efectividad Del Trasplante Renal Comparado Con La Diálisis En Colombia

    Nov 1, 2013, 00:00

  • High Dosages of Statins in High Cardiovascular Risk Patients in a Real World Setting- Treatment Patterns and Outcomes

    Nov 1, 2013, 00:00

  • Assessing the Economic Burden and Health Care Utilizations of Veteran Patients Diagnosed with Chronic Kidney Disease in the United States

    Nov 1, 2013, 00:00

  • Investing in European Health RD – A Pathway to Sustained Innovation and Stronger Economies

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Insulin Detemir in T2DM Patients Poorly Controlled with NPH Insulin in Poland

    Nov 1, 2013, 00:00

  • Value Chain Analysis for Cardiac Devices

    Nov 1, 2013, 00:00

  • Economic Evaluations of Varicella and Herpes Zoster Vaccination Programmes- A Systematic Review

    Nov 1, 2013, 00:00

  • Different Discounting Approaches and Their Impact in Economic Evaluation- A Practical Example Using Hepatitis B Vaccination

    Nov 1, 2013, 00:00

  • Efficacy of Long-Acting Injectable Antipsychotic Therapies in Maintenance Treatment of Schizophrenia- A Mixed Treatment Comparison (MTC) of Double-Blind Randomized Clinical Trials

    Nov 1, 2013, 00:00

  • Symptoms of COPD in Urban Russia Among Adults 40 Years and Older

    Nov 1, 2013, 00:00

  • Costs of Hormonal Receptor Positive, Her 2 Negative Metastatic Breast Cancer (MBC-HR+) in Brazilian Private System (BPS)- A Real World and Published Literature Analysis

    Nov 1, 2013, 00:00

  • Lifetime Cost-Effectiveness of Concomitant Aortic Valve Replacements in France and the United Kingdom

    Nov 1, 2013, 00:00

  • A Budget Impact Analysis to Estimate the Economic Impact of Drug Eluting Balloon for the Treatment of Peripheral Vascular Disease

    Nov 1, 2013, 00:00

  • There Is More to Decision Making Than Costs and Effects- Handling Practical Constraints in the Value of Information Framework

    Nov 1, 2013, 00:00

  • Estimación De La Costo-Efectivadad Del Uso De Daptomicina Vs Vancomicina En Pacientes Con Bacteriemia Y/O Endocarditis Por S. Aureus Resistente a Meticilina

    Nov 1, 2013, 00:00

  • Economic Evaluation of Liraglutide for Treatment of Type 2 Diabetes Mellitus in the Russian Federation

    Nov 1, 2013, 00:00

  • Scoring the Center for Epidemiologic Studies – Depression Scale- Which Items Go Where?

    Nov 1, 2013, 00:00

  • Costo-Efectividad De Tres Estrategias Diagnosticas Para La Identificación De Infección Bacteriana Severa En Lactantes Febriles Sin Foco

    Nov 1, 2013, 00:00

  • How to Determine Size of Patient Population When the Right Data Isn’t There?

    Nov 1, 2013, 00:00

  • Quality Assessment of Observational Studies for Systematic Reviews

    Nov 1, 2013, 00:00

  • Clinical Benefits of Immunosuppression Therapy in Renal Trasplant Patients. Systematic Review and Meta-Analysis

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Paliperidone Palmitate in National Health Service (NHS) Wales- A Cost Utility Analysis Based on the National Institute for Health and Care Excellence (NICE) Core Model for the Management of Schizophrenia

    Nov 1, 2013, 00:00

  • Assessment of the Key Drivers of Cost-Effectiveness in the Economic Modelling of Canagliflozin (CANA) Versus Glimepiride (GLIM) in the Treatment of Type 2 Diabetes Mellitus (T2DM) in the UK Setting

    Nov 1, 2013, 00:00

  • Differences in the Weighted Average Daily Doses of Statins in Latin America and Their Potential Impact on Cardiovascular Outcomes

    Nov 1, 2013, 00:00

  • A Comparison of German Benefit Assessments by G-Ba, IQWiG and Manufacturers

    Nov 1, 2013, 00:00

  • Assessing Measurement Equivalence of Different Forms of Administration of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) Using Rasch Analysis

    Nov 1, 2013, 00:00

  • The Volume-Outcome Relationship and Minimum Volume Standards – Empirical Evidence for Germany

    Nov 1, 2013, 00:00

  • Economic Evaluation of Fulvestrant 500 Mg Versus Generic Non-Steroidal Aromatase Inhibitors in Patients with Advanced Breast Cancer in Norway

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Sapropterin Versus Phenylalanine Free Diet in Patients with Phenylketonuria in Egypt

    Nov 1, 2013, 00:00

  • Health-Economic Comparison of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections for the Treatment of Type 1 Diabetes in Kazakhstan Children

    Nov 1, 2013, 00:00

  • Indirect Costs of Systemic Lupus Erythematosus-Related Absenteeism in Poland- An Analysis Based on Social Insurance Institution Data

    Nov 1, 2013, 00:00

  • The 2013 Revision to Nice’s Discounting Guidelines- Differential Discounting Has Gone But Unjustified Selective Application Remains

    Nov 1, 2013, 00:00

  • Análisis De Costo Efectividad De Acido Gadoterico Frente a Otros Medios De Contrastes Basados En Gadolinio

    Nov 1, 2013, 00:00

  • Acceptability of Indirect Evidence to Support Drug Reimbursement in Australia

    Nov 1, 2013, 00:00

  • Head to Head Economic Evaluation of Two Genomic Profiles of Recurrence Risk for Breast Cancer, Mammaprint Versus Oncotype DX, in Spain

    Nov 1, 2013, 00:00

  • Cross-Country Comparison of Prescribing Patterns Versus Portugal and Potential Cost-Savings

    Nov 1, 2013, 00:00

  • Uso De Bases De Datos O Sistemas De Información Para Soportar La Toma De Decisiones En Salud En Colombia

    Nov 1, 2013, 00:00

  • The Role of Communication and Health Literacy on Patient Safety in Public Pharmacies in the Republic of Srpska

    Nov 1, 2013, 00:00

  • Structural Validation of the Chronic Venous Insufficiency Quality of Life Questionnaire-14 (CIVIQ-14) - A Confirmatory Factor Analysis

    Nov 1, 2013, 00:00

  • Assessment of Real-World Usage of Lanreotide (Somatuline Autogel) 120 Mg in Polish Acromegalic Patients – Results from 1 Year Prospective Phase of Lanro-Study

    Nov 1, 2013, 00:00

  • ‘Big Data’ in Health Care. What Does It Mean and Will It Make a Difference?

    Nov 1, 2013, 00:00

  • Cost Effectiveness of Anti-Oxidant Vitamin + Zinc Treatment to Prevent the Progression of Intermediate Age Related Macular Degeneration to Its Wet Form. A Singapore Perspective

    Nov 1, 2013, 00:00
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116 (current)
  • 117
  • 118
  • 119
  • 120
  • »